306 related articles for article (PubMed ID: 22359740)
1. Fluorodeoxyglucose positron emission tomography in Richardson’s syndrome and progressive supranuclear palsy-parkinsonism.
Srulijes K; Reimold M; Liscic RM; Bauer S; Dietzel E; Liepelt-Scarfone I; Berg D; Maetzler W
Mov Disord; 2012 Jan; 27(1):151-5. PubMed ID: 22359740
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of MRI parameters in pure akinesia with gait freezing.
Nakahara K; Nakane S; Kitajima M; Masuda-Narita T; Matsuo H; Ando Y
J Neurol; 2020 Mar; 267(3):752-759. PubMed ID: 31745723
[TBL] [Abstract][Full Text] [Related]
4. The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.
Seckin ZI; Duffy JR; Strand EA; Clark HM; Utianski RL; Machulda MM; Botha H; Ali F; Thu Pham NT; Lowe VJ; Whitwell JL; Josephs KA
Parkinsonism Relat Disord; 2020 Dec; 81():34-40. PubMed ID: 33045651
[TBL] [Abstract][Full Text] [Related]
5. Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants.
Street D; Malpetti M; Rittman T; Ghosh BCP; Murley AG; Coyle-Gilchrist I; Passamonti L; Rowe JB
Brain Commun; 2021; 3(3):fcab206. PubMed ID: 34541533
[TBL] [Abstract][Full Text] [Related]
6. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
Arabia G; Quattrone A
Mov Disord; 2011 Jul; 26(8):1575-6; author reply 1576. PubMed ID: 21469210
[No Abstract] [Full Text] [Related]
7. Positron emission tomography imaging of tau pathology in progressive supranuclear palsy.
Coakeley S; Cho SS; Koshimori Y; Rusjan P; Harris M; Ghadery C; Kim J; Lang AE; Wilson A; Houle S; Strafella AP
J Cereb Blood Flow Metab; 2017 Sep; 37(9):3150-3160. PubMed ID: 28155586
[TBL] [Abstract][Full Text] [Related]
8. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
[TBL] [Abstract][Full Text] [Related]
9. Thalamic hypoperfusion in early stage of progressive supranuclear palsy (Richardson's syndrome): report of an autopsy-confirmed case.
Kobayashi Z; Akaza M; Ishihara S; Tomimitsu H; Inadome Y; Arai T; Akiyama H; Shintani S
J Neurol Sci; 2013 Dec; 335(1-2):224-7. PubMed ID: 24075472
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
[TBL] [Abstract][Full Text] [Related]
11. [
El Ouartassi A; Giordana C; Schiazza A; Chardin D; Darcourt J
Brain Imaging Behav; 2023 Dec; 17(6):619-627. PubMed ID: 37474673
[TBL] [Abstract][Full Text] [Related]
12. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
Longoni G; Agosta F; Kostić VS; Stojković T; Pagani E; Stošić-Opinćal T; Filippi M
Mov Disord; 2011 Feb; 26(2):247-55. PubMed ID: 21412831
[TBL] [Abstract][Full Text] [Related]
13. Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism.
Nigro S; Barbagallo G; Bianco MG; Morelli M; Arabia G; Quattrone A; Gasparini S; Cascini GL; Quattrone A
Parkinsonism Relat Disord; 2019 Dec; 69():23-29. PubMed ID: 31665684
[TBL] [Abstract][Full Text] [Related]
14. Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS-PSP Criteria.
Martí-Andrés G; van Bommel L; Meles SK; Riverol M; Valentí R; Kogan RV; Renken RJ; Gurvits V; van Laar T; Pagani M; Prieto E; Luquin MR; Leenders KL; Arbizu J
Mov Disord; 2020 Nov; 35(11):2009-2018. PubMed ID: 32822512
[TBL] [Abstract][Full Text] [Related]
15. Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.
Asahina M; Suhara T; Shinotoh H; Inoue O; Suzuki K; Hattori T
J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):155-63. PubMed ID: 9703164
[TBL] [Abstract][Full Text] [Related]
16. Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease.
Lee YE; Williams DR; Anderson JF
J Neuropsychol; 2016 Mar; 10(1):1-14. PubMed ID: 25223526
[TBL] [Abstract][Full Text] [Related]
17. Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study.
Nigro S; Antonini A; Vaillancourt DE; Seppi K; Ceravolo R; Strafella AP; Augimeri A; Quattrone A; Morelli M; Weis L; Fiorenzato E; Biundo R; Burciu RG; Krismer F; McFarland NR; Mueller C; Gizewski ER; Cosottini M; Del Prete E; Mazzucchi S; Quattrone A
Mov Disord; 2020 Jun; 35(6):976-983. PubMed ID: 32092195
[TBL] [Abstract][Full Text] [Related]
18. Improved Automatic Morphology-Based Classification of Parkinson's Disease and Progressive Supranuclear Palsy.
Talai AS; Ismail Z; Sedlacik J; Boelmans K; Forkert ND
Clin Neuroradiol; 2019 Dec; 29(4):605-614. PubMed ID: 30218110
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
[TBL] [Abstract][Full Text] [Related]
20. Dopamine transporter imaging in progressive supranuclear palsy: Severe but nonspecific to subtypes.
Chen QS; Li XY; Li L; Lu JY; Sun YM; Liu FT; Zuo CT; Wang J
Acta Neurol Scand; 2022 Sep; 146(3):237-245. PubMed ID: 35611608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
